FOXO4-DRI (Proxofim) – Premium Senolytic Research Peptide
Advanced Cellular Senescence Research
FOXO4-DRI (Proxofim) is a cutting-edge senolytic research peptide engineered to selectively disrupt the FOXO4–p53 interaction observed in senescent cells. By targeting this specific protein binding mechanism, FOXO4-DRI reactivates apoptotic signaling pathways in senescent (“zombie”) cells while leaving healthy cells unaffected in preclinical models.
Designed as an all–D amino acid D-retro-inverso peptide, FOXO4-DRI offers enhanced stability and precision for advanced laboratory investigation into:
•Cellular senescence mechanisms
•Apoptosis signaling pathways
•Longevity and rejuvenation research models
•Age-related disease pathway studies
⸻
Why Researchers Choose FlawlessBioLabs
•High-purity research-grade material
•Ideal for in vitro and preclinical applications
•Reliable sourcing for serious research institutions
FlawlessBioLabs is committed to supplying high-integrity research compounds to qualified professionals pushing the boundaries of cellular science.
⸻
Important Research Disclaimer
FOXO4-DRI is an investigational research compound.
•For laboratory research use only
•Not for human or veterinary use
•Not for diagnostic or therapeutic purposes
•Not approved by the FDA or any regulatory authority
•Safety and efficacy in humans have not been established
All products sold by FlawlessBioLabs are intended strictly for research and educational purposes. The purchaser assumes full responsibility for proper handling and regulatory compliance.
Note: This product is provided as a Lyophilized, research-grade powder and does not come in liquid form.
Disclaimer
Research Use Only Disclaimer:
Products from Flawless BioLabs are strictly for laboratory and research use by qualified professionals. They are not pharmaceuticals, dietary supplements, agricultural products, or household items, and must not be mislabeled as such. These chemicals are not intended for human or veterinary use and are exempt from Title 21, Parts 100–740 of the CFR. The information provided is educational, has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any health condition.
Intellectual Property & Patent Use Disclaimer: Flawless BioLabs provides this product solely for uses that fall under exemptions to patent infringement as permitted by applicable law, including but not limited to 35 U.S.C. § 271(e)(1) in the United States. It is the sole responsibility of the purchaser or user to ensure that their use of this product complies with all applicable intellectual property laws and legal exemptions. By purchasing this product, the buyer agrees to use it only within the scope of those exemptions and to indemnify and hold harmless Flawless BioLabs from any claims arising from its use, including any alleged intellectual property infringement.
